President's Cancer Panel Meeting- The Future of Cancer Research: Accelerating Scientific Innovation, Transcript of Proce by National Cancer Institute . - HTML preview

PLEASE NOTE: This is an HTML preview only and some elements such as links or page numbers may be incorrect.
Download the book in PDF, ePub, Kindle for a complete version.

 

OVERVIEW

This meeting was the first in the President’s Cancer Panel’s (PCP, the Panel) 2010-2011 series, The Future of Cancer Research: Accelerating Scientific Innovation. During this meeting, the Panel heard expert testimony and moderated discussions regarding scientific progress made over the past four decades and opportunities to enhance the National Cancer Program (NCP) in coming years. The agenda for the meeting was organized into two discussion panels.

PARTICIPANTS

President’s Cancer Panel

LaSalle D. Leffall, Jr., M.D., F.A.C.S., Chair

Margaret Kripke, Ph.D.

National Cancer Institute (NCI), National Institutes of Health (NIH )

Abby Sandler, Ph.D., Executive Secretary, PCP

Speakers

John Auerbach, M.B.A., President-Elect, Association of State and Territorial Health Officials

Edward J. Benz, Jr., M.D., President, Dana-Farber Cancer Institute

Otis W. Brawley, M.D., Chief Medical Officer, American Cancer Society

Bruce Chabner, M.D., Co-Chair, The National Cancer Advisory Board’s Ad hoc Working Group to Create a Strategic Scientific Vision for the National Cancer Program and Review of the National Cancer Institute

Gwen Darien, Chair, Director’s Consumer Liaison Group, National Cancer Institute

James Doroshow, M.D., Director, Division of Cancer Treatment and Diagnosis, National Cancer Institute Judy E. Garber, M.D., M.P.H., President-Elect, American Association for Cancer Research

Peter Grevatt, Ph.D., Director, Office of Children's Health Protection and Environmental Education, Environmental Protection Agency

William Hait, M.D., Ph.D., Senior Vice President and Worldwide Head, Ortho Biotech Oncology Research & Development, a Unit of Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Brandon Hayes-Lattin, M.D., Senior Medical Advisor, Lance Armstrong Foundation

Michael Kelley, M.D., F.A.C.P., National Program Director for Oncology, Veterans Health Administration, Department of Veterans Affairs

Sharyl Nass, Ph.D., Director, National Cancer Policy Forum, Institute of Medicine

Richard Pazdur, M.D., F.A.C.P., Director, Office of Oncology Drug Products, Center for Drug Evaluation and Research, Food and Drug Administration

 Kyu Rhee, M.D., M.P.P., F.A.A.P., F.A.C.P., Chief Public Health Officer, Health Resources and Services Administration

Lisa Richardson, M.D., M.P.H., Associate Director for Science, Division of Cancer Prevention and Control, Centers for Disease Control and Prevention

George W. Sledge, Jr., M.D., President, American Society of Clinical Oncology

Barry Straube, M.D., Chief Medical Officer, Centers for Medicare and Medicaid Services